Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT05300334
Eligibility Criteria:
Inclusion Criteria:
1. Signing of the written informed consent form by the patient and/or his legal representative,
2. The presence of lymphopenia as a result of at least one hemogram of the patient,
* The number of lymphocytes should be below 3000/mm3 for the first 0-12 months
* The number of lymphocytes dec below 1500/mm3 for the first 13 months- ≤ 40 years
3. The patient should be 0- ≤ 40 years of age
Exclusion Criteria:
1. The patient was diagnosed with ADA enzyme deficiency before being included in the study,
2. The patient has participated in an interventional clinical trial within the last 30 days,
3. Failure of the patient himself and/or his legal representative to give their consent to participate in the study,
4. According to the researcher's opinion, the patient will not be able to properly fulfill the study requirements,
5. Pregnancy and/or lactation period
6. The fact that the volunteer participating in the study received an erythrocyte suspension or a complete blood transfusion within the last 3 months.
Sex:
ALL
Maximum Age:
40 Years
Study:
NCT05300334
Study Brief:
Protocol Section:
NCT05300334